Nuclear Countermeasures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

With questions from carolyn maloney. I want to ask about testing. Why being asked over again the United States is so far behind other countries and why the American People cannot get tested. Our first case of coronavirus was on january 21. The u. S. Has tested 4900 people. In contrast, south korea has tested almost 200,000 people. They can test 15,000 people a day. South korea contest more people in one day then we tested over the past two months. So, dr. Fauci, why are we so far behind korea in testing and reporting this crisis . Dont like to pass the buck. Numbers. Eld has the i dont have th...

We have a change in schedule. As we explained in the hearing memo, we were planning to do Opening Statements from 9 30 to 10 00 and testimony and questions from 10 00 to 1 00. This morning we were informed that President Trump and Vice President pence have called our witnesses to about emergency meeting at the white house. We dont know the details just that it is extremely urgent. Now the witnesses have to leave at 11 45. In light of the sudden change we will significantly reduce Opening Statements. We will do 10 minutes so we can get right to questions. Witnesses, please keep your oral statem...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K ...

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced new non-dilutive external funding, additional to the previously announced U.S. Government funding, which now covers the entirety of the RHB-107 (upamostat) arm of the ACESO PROTECT adaptive platform trial for early COVID-19 outpatient treatment. This additional funding amounts to approximately $4.8M directed towards evaluation of RHB-107 in the PROTECT study.

RedHill Biopharma Ltd.’s stock soared 10% premarket after the company said it has received a further $1.7 million in U.S. government funding for its partner,...